Table 3.
Population features | Overall cohort
|
Patients aged 45–84 years
|
||
---|---|---|---|---|
HR (CI) | P-value | HR (CI) | P-value | |
Age, years | 1.07 (1.06–1.07) | <0.001 | 1.06 (1.06–1.06) | <0.001 |
Females vs males | 0.76 (0.73–0.78) | <0.001 | 0.74 (0.71–0.77) | <0.001 |
Severity score 1 vs 0 | 1.39 (1.34–1.44) | <0.001 | 1.45 (1.40–1.51) | <0.001 |
Severity score 2 vs 0 | 1.69 (1.57–1.82) | <0.001 | 1.83 (1.68–1.99) | <0.001 |
Charlson 1 vs 0 | 1.31 (1.26–1.36) | <0.001 | 1.39 (1.32–1.45) | <0.001 |
Charlson 2 vs 0 | 1.57 (1.50–1.64) | <0.001 | 1.70 (1.61–1.80) | <0.001 |
Charlson 3+ vs 0 | 1.84 (1.74–1.95) | <0.001 | 1.99 (1.86–2.13) | <0.001 |
CKD | 1.36 (1.30–1.42) | <0.001 | 1.41 (1.33–1.50) | <0.001 |
Notes: Severity score was defined by none, one, or both of the following criteria: an hospital diagnosis or an exemption from medical charges due to respiratory failure; previous hospitalizations for COPD. Modified Charlson index: the modified version of the Charlson Comorbidity Index (CCI) adapted to ICD-9-CM codes was adopted based on diseases reported during hospitalizations.
Abbreviations: HR, hazard ratio; CI, confidence interval; CKD, chronic kidney disease; ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification.